Why We Ran a Clinical Trial for an Ayurvedic PCOS/PCOD Solution
Women with PCOS/PCOD are constantly asked to make decisions about their health.
Should I try this supplement?
Will this approach actually help?
What evidence is there?
These are fair questions. In fact, they're the same questions we asked ourselves while developing the Divantri PCOS/PCOD Pack.
Ayurveda has supported women's health for centuries, and many of its principles continue to guide our work today. At the same time, we felt that tradition alone wasn't enough. Women deserve access to evidence, and healthcare professionals deserve data they can evaluate and discuss openly.
That's why we chose to run a clinical trial.
A clinical trial is a carefully designed study that helps researchers understand how a treatment performs in real people. It allows outcomes to be measured over time, rather than relying on individual experiences or anecdotes.
For our Phase III clinical trial, we worked with 200 women and followed their progress over 120 days.
We didn't want to focus on just one symptom.
PCOS/PCOD affects many aspects of health at the same time, so the study evaluated outcomes that women and healthcare professionals commonly monitor.
| What We Measured | Why It Matters |
|---|---|
| Menstrual cycle regularity | More predictable cycles are an important goal for many women with PCOS/PCOD |
| LH:FSH ratio | A hormone pattern often associated with ovulation |
| Free testosterone | Often linked to symptoms such as acne, facial hair growth, and hair thinning |
| Ovarian cyst size | Commonly monitored in women with PCOS/PCOD |
| Safety markers | Helps understand how well a formulation is tolerated |
Over the course of the study, improvements were observed across several measured outcomes:
- 32.6% improvement in menstrual cycle regularity
- 71.25% improvement in LH:FSH ratio towards normalization
- 58.7% reduction in free testosterone levels
- 55.67% reduction in average ovarian cyst size
The study also monitored safety throughout the trial period. No serious adverse events were reported, and liver and kidney function markers remained within normal limits.
Numbers are important, but women don't experience PCOS/PCOD through lab reports alone.
They experience it through everyday life. A more predictable cycle. Greater confidence in understanding their bodies. Progress that feels meaningful to them.
At DurvaLife, we believe traditional knowledge and modern research belong in the same conversation. Running a clinical trial was our way of bringing those two worlds together and giving women access to information they can trust.
Note: Healthcare decisions should always be made in consultation with a qualified healthcare professional. Individual responses to treatment may vary.
References
DurvaLife Clinical Evidence
DurvaLife Divantri PCOS/PCOD Pack Phase III Clinical Trial (CTRI/2024/08/072073)
Additional Reading
International Evidence-Based Guideline for the Assessment and Management of PCOS/PCOD (2023)
World Health Organization (WHO): Polycystic Ovary Syndrome Fact Sheet
National Institutes of Health (NIH): Understanding Clinical Trials
Share
